Corrigendum: Clinical Characteristics and Neurologic Outcomes of X-Linked Myotubular Myopathy

Article information

Ann Child Neurol. 2022;30(4):220-220
Publication date (electronic) : 2022 September 28
doi : https://doi.org/10.26815/acn.2022.00171.e1
1Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children’s Hospital, Seoul, Korea
2Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Korea
3Department of Genomic Medicine, Seoul National University Children’s Hospital, Seoul, Korea
4Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea
5Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea
6Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea
Corresponding author: Jong-Hee Chae, MD Department of Pediatrics, Seoul National University Children’s Hospital, 101 Daehak-ro, Jongnogu, Seoul 03080, Korea Tel: +82-2-2072-1709 Fax: +82-2-2072-3917 E-mail: chaeped1@snu.ac.kr

Ann Child Neurol 2022;30(3):127-133

https://doi.org/10.26815/acn.2022.00171

The article by Woo H, et al. entitled, "Clinical Characteristics and Neurologic Outcomes of X-Linked Myotubular Myopathy" (Ann Child Neurol 2022;30(3):127-133) contained an error in the IRB number.

Before correction

The Institutional Review Board (IRB) of the Seoul National University Hospital approved this study (IRB no. 1101-110-353) and waived the requirement for informed consent.

After correction

The Institutional Review Board (IRB) of the Seoul National University Hospital approved this study (IRB no. 2204-177-1320) and waived the requirement for informed consent.

The authors apologize for any inconvenience that it may have caused.

Article information Continued